FDA Approves Leucovorin for Autism Treatment
Source: What Is Leucovorin, the Medicine Being Approved for Autism Treatment? (2025-09-23)
The FDA has approved leucovorin as a treatment for children with autism spectrum disorder (ASD), marking a significant development in autism care. The decision follows recent clinical trials indicating that leucovorin can improve social and communication skills in some children with ASD, offering a new therapeutic option where few exist. Researchers emphasize that while leucovorin shows promise, it is not a cure and should be used alongside other therapies. The approval has sparked both hope among families and discussions within the medical community about personalized treatment approaches and the need for further research to understand which patients are most likely to benefit.
More recent coverage
- Penn State Punter Gabe Nwosu Named to Ray Guy Watchlist
- Prairieville Woman Pleads No Contest in Teen Sex Case
- Marvel’s Wolverine Coming to PS5 in Fall 2026
- NIH Launches $50M Autism Data Science Initiative
- Google Marks 20 Years in Mexico
- John Fogerty Reclaims His Music with New Remakes
- Rylee Arnold Shares Experience Dancing with Scott Hoying
- London Mayor Sadiq Khan Labels Trump 'Racist, Sexist, Islamophobic'